See how AI has transformed Yiwu shop owners into polyglots in China!
BEIJING, Feb. 14, 2025 /PRNewswire/ --A news report by China.org.cn on China's AI application: See how AI has transformed Yiwu shop owners into polyglots in China! A toy store owner speaks dozens of languages? No kidding? In Yiwu, the world's...
WORK Medical Technology Group LTD Reports Financial Results for Fiscal Year 2024
HANGZHOU, China, Feb. 14, 2025 /PRNewswire/ -- WORK Medical Technology Group LTD ("WORK Medical" or the "Company") (Nasdaq: WOK), a supplier of medical devices in China, today reported its financial results for the fiscal year ended September 30,...
Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases
BOSTON, Feb. 14, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa), a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders, today announced the successful completion of its...
Tuya to Report Fourth Quarter 2024 Financial Results on February 26, 2025 Eastern Time
SANTA CLARA, Calif., Feb. 14, 2025 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading cloud platform service provider, today announced that it will report its fourth quarter 2024 unaudited financial...
Thousand-year-old temple fair held in Central China's Henan
XUN COUNTY, China, Feb. 14, 2025 /PRNewswire/ -- On February 6, 2025, the ninth day of the first lunar month, the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibrant display of traditional...
Snail Games Celebrates Pivotal Milestones and New Content for the ARK Franchise
CULVER CITY, Calif., Feb. 14, 2025 /PRNewswire/ -- Snail Games (Nasdaq: SNAL), a premier global developer and publisher of interactive digital entertainment, celebrates new milestones that are reshaping the ARK universe. The franchise has expanded...
Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA
SHENZHEN, China, Feb. 14, 2025 /PRNewswire/ -- Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05, Human Interferon α1b Inhalation Solution, a self-developed product by...
LONGi maintains AAA ranking in Q4 2024 PV ModuleTech Bankability Ratings
XI'AN, China, Feb. 14, 2025 /PRNewswire/ -- LONGi has announced the retention of its AAA rating in PV-Tech's Q4 2024 PV ModuleTech bankability ratings, marking the company's 20th consecutive quarter at this top tier and underscoring its long-term...